KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Capital Employed: 2010-2025

Historic Return on Capital Employed for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to 0.09%.

  • Emergent BioSolutions' Return on Capital Employed rose 20.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 20.00%. This contributed to the annual value of -0.08% for FY2024, which is 32.00% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Return on Capital Employed stood at 0.09%, which was up 10.58% from 0.08% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Capital Employed registered a high of 0.21% during Q1 2021, and its lowest value of -0.60% during Q4 2023.
  • For the 3-year period, Emergent BioSolutions' Return on Capital Employed averaged around -0.24%, with its median value being -0.18% (2023).
  • Per our database at Business Quant, Emergent BioSolutions' Return on Capital Employed plummeted by 61bps in 2023 and then skyrocketed by 52bps in 2024.
  • Over the past 5 years, Emergent BioSolutions' Return on Capital Employed (Quarterly) stood at 0.13% in 2021, then dropped by 23bps to -0.09% in 2022, then slumped by 51bps to -0.60% in 2023, then skyrocketed by 52bps to -0.09% in 2024, then rose by 20bps to 0.09% in 2025.
  • Its Return on Capital Employed was 0.09% in Q3 2025, compared to 0.08% in Q2 2025 and -0.08% in Q1 2025.